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The requirements for grow th factors of human melano-
cytes in culture m ay be dependent on the stage of malignant 
transformation. Several factors synergistically promote the 
viability and proliferation of human neonatal melanocytes 
in culture. They are TPA (12-0-tetradecanoyl-phorbol-13-
acetate) , isobutylmethyl xanthine, cholera toxin , and as yet 
unidentified factors from extracts derived from several cell 
lines and human placenta. N eonatal melanocytes can main-
tain at least 50 population doublings during a period of 6 
months, whereas melanocytes from adult skin proliferate 
only fo r 1 month and at less than 1 % of the proliferative 
ra te of melanocytes derived from newborn foreskins . In 
M elanocytes isolated from newborn fores kins pro-lifera te well in culture in the presence of TIC [a mixture of TPA (12-0-tetradecanoly-phorbol-13-acetate), IBMX (isobutyl methyl xanthine), and/or CT (cholera toxin)] [1-3] . Extrac ts from 
bovine brain [4] and from some cell lines that do not need T PA 
to proliferate in culture, in particular the WI-38 human fi broblas tic 
cell line (5) , can substitute for TPA . Under identical conditions 
human m elanocytes derived fro m the skin of adults undergo only 
a few cell divisions and then become quiescent, though they con-
tinue to need TP A and CT to survive rl]. Because some malignant 
m elanocytes derived from metas tatic lesions proliferate in culture 
w ithout these mitogens, it appea rs that at some point during 
transformation to melanoma cells, melanocytes acquire indepen-
dence from these growth stimulators . Because a relationship be-
tween natural grow th fac tors, receptors for growth factors, and 
oncogenes exists in several o ther cellular systems [6- 9]. we have 
examined melanocytes from different lesions with respect to .their 
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Abbrevia tions: 
CT: cholera toxin 
IBMX: isobutylmethyl xanthine 
IC: medium supplemented with 0. 1 mM IBMX and 2.5 nM CT 
MEMS: Eagle's minimal essential medium without calcium and 
magncsiun 
PBS: salinc-phosphate buffer solution 
TIC: mixtLIre ofTPA, IBMX, and CT 
TPA: 12-0-tetradecanoyl-phorbol-1 3-acetate 
contras t, melanocytes from dysplas tic and congenital nevi 
proliferate well in the presence of mitogens during the 
initial 4-6 weeks of culture, but then become quiescent. 
Melanocytes from primary melanom as are the most dif-
fi cult to grow in culture. They need the mitogens, but their 
rate of proliferation is slow. M ost of the metastatic mel-
anocyte strains that do not need the mitogens in order to 
prolifera te, are strongly inhibited by TPA, and to a lesser 
extent by WI-38 cell extract. We conclude that the acqui-
sition of independence fro m mitogens in culture is a late 
event in the transformation of melanocytes to melanomas. 
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ability to grow in culture independently of T IC . We demonstrate 
here the synergistic effect o f IBMX and/or C T on growth stim-
ulation of neonatal melanocytes in combination with TP A and 
va rious extracts. In addi tion, we demonstra te that melanocytes 
from congenital and dysplas tic nevi, considered to be precursors 
for melanomas [1 0], and those from a primary melanoma, all 
require TIC to divide in culture. Their proliferative responses to 
TIC are different from those of neonatal and adult normal mel-
anocytes. In contras t, melanocytes fro m metastases that grow in 
vitro independentl y o f TIC are highly inhibited by these fac tors. 
MATERIALS AND METH ODS 
Cell Culture N ormal neonatal human melanocytes were grown 
by a method modified by us [3] fr0111 that of Eisinger and M arko 
[1]. Foreskins fro m newborns were cleaned of connective tissue 
and incubated in Eagle's minimal essential medium without cal-
cium and m agnesium (MEMS), supplemen ted with 0.25 % tryp-
sin , 200 units/ml penicill in, 100 ILg/ m! streptomycin , and 85 nM 
TPA (Consolidated Midland Corporation) at 4°C, overnight. T he 
epidermis was separated fro m the dermis, tissues were shaken 
vigorously, and detached cells were plated in melanocyte growth 
medium (TIC medium). The latter consisted of H am 's F-lO me-
dium (American Biorganics) containing 8% Nu-serum (Collab-
orative Resea rch, Inc.), 8% newborn calf seru m (GIBCO Lab-
oratories), penicill in and strepto mycin , plus 85 nM T PA, 0. 1 mM 
IBMX (Sigma Chemical Company), and 2.5 nM CT (List Bio-
logical Laboratories) . We found the phosphodiesterase inhibitor 
IBMX to be highl y mitogenic to melanocytes synergistically w ith 
TPA (see Results). When necessary, contaminating fibroblasts were 
eliminated by incubating the cultu res for 3-4 days in TIC medium 
supplemented with 100 ILg/ml geneticin (G418 sulfa te, GIBC O 
Laboratories) [3]. Fibroblas ts were killed selecti vely by this trea t-
ment while the melanocytes continued to proliferate. Fresh growth 
medium was given twice a week. T he cells were passed at a ratio 
ofl : 3 once every 7-14 days. The trypsin solution described above 
was applied for 5- 10 min to resuspend the cells for the purpose 
of transfer. 
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Table I. C lini ca l Pathologic Correlati ons 
Case Sex Age 
LD F 32 
JZ F 41 
MM F 63 
PS M 48 
RD F 9 
Site and T ype of Lesion 
Back, dysplastic nevus 
Back, dysplastic nevus 
Back, dyspl astic nevus 
Abdomen, dysplastic nevus 
Back, compound congenital nev us 
Shape of Melanocytcs 
Cuboidal 
Cuboid:!1 
Cuboidal rarely spind ly 
Cuboidal occas ionall y spindle 
Cuboid :!1 
Paticnt's History 
ONS 
ONS, Mel 
ONS, FM 
ON , MeI 
ON 
TS M 47 Forearm, co mpound nevus, congen ital with Epithelioid , pleomorphic 
junction:!1 atypicality 
CQ M 45 Chest, intraductal nevus, congenital Round epithelioid 
SA M 33 Back, compound nevus, congenital Epithelioid 
MH F 29 Arm , congenital nevus, gi:!nt Cu boidal, sm:! 11 
RP F 63 Thigh, dysplastic nevus in a giant congenit:!1 Cuboid:!1 
Mel 
Mel 
nevus 
MO F 41 Groin , melanoma, superfic ial sprc:!ding, Cuboida l or epithelioid Mcl 
regressing 
SR M 29 Leg, mel :! llom:! , metastatic Epithelioid 
PC F 31 Leg, melanoma, metastatic Spindle or epithelioid 
MS F 55 Neck, melanoma in situ, superfi ci:!1 spreading Pagetoid , epithelioid 
Mel 
Mel 
Mel 
Mel 
Mel 
EJ M 70 Back, melanoma, recurrent satellite nodule Spindle shaped or epithelioid 
JH M 60 Arm, melanoma, recurrent subcutaneous Large epithelioid 
LG F 45 
Key: DNS = 'dysplastic nevus syndrome. 
FM = fami ly history o f melanoma . 
Mel = history of melanoma. 
- = no DNS or melanoma. 
tissue 
Brain , melanoma, met:!st:!tic 
Adu lt ep idermal melanocytes were derived from no rm al ski n 
by shave biopsies. The specimens (total, 10 in number) were 
treated as described above except that trypsin was applied only 
fo r 2-3 h. 
Melanocytes were also cultured from 15 congenital and 24 dy~­
plas ti c nevi, and from 12 primary and 12 metastatic melanomas. 
T he sources of the cultures on which we carried out growth 
experim ents are g iven in Table I. Half of each bio psy specimen 
was used for dermatopathologic evaluation of th e lesion and the 
other half fo r cell culture. In the latter case, the skin ti ss ues were 
incubated in the above trypsin solu tion at 4°C for 8-16 h. After 
vigorous shaking over a vortex mixer for 1 min, the dissociated 
cells were seeded into two 4-cm2 wells (Costar) . The remainders 
of the tissue sa mples were incubated with collagenase (200 U / ml) 
in MEMS medium at 37°C for 4-16 h . Loosened cells were aga in 
dissociated by vigorous shakin g and added to the established wells. 
One culture of each pair o f wells was incubated with TIC medium 
an d th e o ther w ith melanoma medium . The latter is melanocyte 
growth medium minus T IC. Again, fibrobla sts were eliminated 
by incubating the cu ltures in geneticin in T IC medium for 2 days. 
Cell Proliferation During the initial weeks in culture, the cells 
were checked daily with the phase microsco pe. For quantitative 
analysis of growth , we measured the incorporation o f[3H]th ymidine 
into DNA. The cells were seeded in 4-cm2 wells at 70% con-
flu ency (approximately 80,000 cells/well) and maintained in ex-
perimental medium for 4-5 days with a change of medium on 
day 3. The cultures were th en incubated with [3H]th ymidine 
(5 /-LC i/ ml, 90 C i/ mmol, Amersham) in MEM S or H am 's F-I0 
medium suppl em ented w ith 3% di alyzed calf serum, fo r 1-3 h 
at 37°C. Th is labeling medium was replaced with 0.25% trypsin 
solution th at was supplemented with 1 mM EDT A to detach the 
cells, and the suspended cells were trapped on no. 30 glass filters 
in the mini fold apparatus of Schleicher and Schuel!. The ftlters 
were washed 3 times w ith di still ed w ater, dried , placed in scin-
tillation fluid , and the radioactivity was determined in a scintil-
lation counter. Cells fro m para llel wells, no t incubated with the 
radioactive medium, were similarly detached and their numbers 
determined with a Coulter Counter. 
Cuboid:!1 or spindle Mel 
Preparation of Extracts The following procedure is a slight 
modifi ca tio n o f that described by E isinger et aIlS] . WI-38 fetal 
lung fibroblas ts, o btained from the American Type C ulture Col-
lection, were grown in 150-cm 2 fl asks in melanoma mediu m . 
Actively growing cells w ere detached with a rubber scraper in 
sa line-phosphate buffer solution (PBS), centrifu ged , and resus-
pended in PBS . This centrifu ga tion-washin g procedure was re-
pea ted twice and the cell pellet was then res uspended in 2 X it 
vo lume with PBS, so ni cated 3 X for 10 s, and centrifu ged at 
13,000 g fo r 10 min. The protein content of the supernatant w as 
determined using the Bio-Rad protein assay and bovine serum 
albumin as a stand ard. T he cell extra ct was diluted with PBS to 
a protein concentrati on of 500 /-Lg/m l, pass.ed throug h a N algene 
fi lter (0.45 /-Lm) , and frozen at - 20°C. 
Bovine brain extra ct was prepared as described [4] and was a 
genero us g ift of Dr. M . H erl yn, th e Wistar Institute, Philadelphia, 
Pennsylvania. Placental extrac t was prepared as follows. Full-
term human placenta was washed extensively with PBS, a po rtion 
was minced , homogenized in PBS using Polytron (Brinkman 
Instruments), and sonicated for 30 s. The homogenate was cen-
trifu ged at 13,000 g for 10 min at 4°C and the supernatant wa 
passed th rough a 0.45-/-Lm N algen filter. 
Tyrosinase Activity Tyrosinase activity was determin ed as 
described before [23]. 
RESULTS 
Stimulation of Growth in Response to IBMX and/ or CT In 
order to determin e optimal culture conditio ns for melanocyte, 
we tested whether IBMX and CT enhanced the growth stimu-
latory activity of TPA (Fig. I , Table II), WI-38 cell extract, and 
bovine brain extract (Table III ). We also tes ted whether human 
placenta ca n be used as an easily access ible source of growth factor. 
The data demo nstrated th at in m edium with TPA, th e growth 
rate of neonatal melanocytes was markedly enhanced b y the ad-
diti on of either IBMX or CT in a concentration-dependent man-
ner (Fig 1) . There was a w ide variation in the response of mel-
anocytes from different donors to short-term deprivation from 
IBMX and CT (Table II). IBMX and CT enhanced also thr 
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Figure 1. Growth response of neonatal melanocytes to IBMX and CT 
in the presence of TPA. Melanocytes from a newborn foreskin were 
grown for 3 months in the presence of T IC. Cells were seeded in 4-c111 2 
cluster wel ls and kept in medium supplemented with TPA (85 nM) and 
different concentrations of either CT (top) or IBMX (bOIIOIll). The incor-
poration of eHJthymidine was measured for 1 h at the end of the 5th 
day in the experimental medium . Values arc average of 2 wells. SE did 
not exceed 7%. 
g rowth stimulatory activity of extracts derived from WI-38 cells, 
bovine brain , and human placenta (Table Ill) . Lon g-term g rowth 
was especiall y dependent on the presence of IBMX and CT, and 
melanocytes eventuall y di ed if kept in only one of the fa cto rs. 
Extract from human placenta suppo rted a hi gher rate of proli f-
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eratio n than extract fro lll bovine brain and was as efficient as TPA 
or WI-38 cell extract. T he grow th stimulato ry activity was re-
stricted to the pla centa and was absent from umbilical chord 
blood. 
Morphology The m o rpho logy of mel anocytes cultured from 
various sources as shown in Table I is presented in Fig 2. Mel-
anocytes fro m shave b iops ies of clini call y nor m al adult skin ap-
peared sm all er in co mpari son w ith m elanocy tes fro m newborn 
fo reski ns, nev i, o r primary melanomas . Melanocy tes from Illost 
nevi and primary melano m as were slender and spindl y, simil ar 
to nconatal mclanocy tcs . The o nl y exception were the mcl ano-
cytes from o nc congenital nevus (CQ, Fig 2C). These cell s were 
larger tlun melanocytes from o th er sources and epithelio id in 
shapc. Likc m os t nconata lmelanocytes grown with TIC, the cells 
from all nevi and primary melanomas were hi g hl y pig m cnted . 
During the initial 1-2 weeks, primary cultures contained fibro-
blasts that were recogni zed by th eir fl at and broad appearance. 
The cultures from ncvi and primary mclano m as differed from 
th ose of no rmal cell s b y th e frequ ent occurren ce of bi- and mul-
tinucl ea ted ce lls . T he m elanocytes frol11 nevi developed several 
processes and los t some of their refractility w hen they beca m e 
:trres ted (Fig 2F). 
Growth Characteristics Melanocy tes frolll nev i and primary 
super fi cial spreading m elano m as did not survive in m edium de-
void of T IC. Within a w eek they beca m e overg rown by fibro-
blasts and the m elanocytes died and lost their attachment to the 
g rowth surface. In the presence of TI C, the melanocytes from 
approximately 40% of the various nev i grew to qu antities suf-
ficient for analysis of growth. In contras t, most of the primary 
superficia l sp reading melano m:t s g rew in mel anocyte m edium at 
an extrem ely slow rate and died within 2 months in culture. 
N either mcl :t noma medium nor TIC m edium was optimal for 
the g rowth of pig ment cells from the e primary m elanomas. In 
patient MD, thc l11el 3nOm3 aro'sc from a dysplas ti c nev us, and 
th e mclanocy rcs from the benign aAd mali gnant parts beha ved 
similarl y in culture. 
Quantitativc analyses of cell growth from biopsies are presented 
in T ables IV and V and in Fi g 3. In th e presence of T IC, m e!:t-
nocytes from newborn foreskins maintained a high DNA syn-
theti c ac tivity even after several passages and several m o nths in 
culture (Table II). As of now, we have cells at passage 18 that 
underwent at least 55 popu lation doublin gs. T he various neonatal 
cell cultures inco rpo rated [3H]th ymidin e at:t wide range and their 
g rowth r:tte decreased dramatically after the removal of IBMX 
:tnd C T , leaving only TPA . Melallocytes from clinicall y normal 
adult sk in had extremcly low DNA synthetic activity, less than 
1 % of that ex hibited by neonatal mel anocytcs (Table IV). Mel-
anocy tes from congenital and d ysplastic nevi initiall y inco rpo-
rated hig h level s of (3H]th ymidine but, unlike neonatal mel ano-
cytes, became quiescent within 4-6 weeks in culture (Table IV , 
Fig 3). An exception w ere melanocytes from congenital nevus 
Table II. Growth of Melanocytes from Newbo rn Foreskins 
Growth Rate 
Culture Grown in T IC 
Experimenta l Culture Conditions 
TIC (100'Yo) TPA No Additions 
Donor Passage N u III ber Weeks (cpm/3 h ± SE) (%) (%) 
1 3rd 5 30,000 ± 130 7.3 0.7 
2 3rd 4 17,500 ± 33 34.0 2.9 
3 3rd 5 25,000 ± 1,021 2.4 0.4 
4 4th 6 15,000 ± 300 73.0 1.3 
5 5th 8 27,000 ± I ,SOO 33.3 2.2 
6 6th 10 102,000 ± 6,500 44.1 S.5 
7 7th 12 85,000 ± 2,000 1. 4 0.2 
8 8th 16 IS,OOO ± 500 16.7 1. 7 
T he cultllres (approx imatel y 80,000 cell s/well) had been established and maintained in med iullI wi th T IC and were exposed to ex perimenta l medi um for 4-5 days. Each 
en try is an average value from 2 well s. Standard erro r (SE) did not exceed 10%. In corporation of [.lHJth ym idinc was assayed during the fina l 1-3 h of incubatio n. 
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Table III. Growth Responses of Melanocy tes to 
Various Factors 
Addi tions 
N one 
T PA 85 nM 
Extracts 
W I-38 50 J,Lg/ ml 
5 J,Lg/ml 
Bovine brain 150 J,Lg/ml 
15 J,Lg/ml 
Human placenta 20 J,Lg/ ml 
4 J,Lg/ ml 
Human placenta 4 J,Lg/ ml 
+ TPA 85 nM 
C ultu re Conditions 
(cpm/well :t SE) 
N one IC 
90 :t 10 452 :t 20 
3, 120 :t 350 10,000 :t 400 
9,500 :t 210 21,250 :t 150 
1,800 :t 290 20,500 :t 750 
200 :t 20 3,200 :t 300 
60 :t 10 450 :t 35 
4,230 :t 450 42,000 :t 1,500 
1,650 :t 70 14,230 :t 700 
Not determined 38,000 :t 1,200 
T he neonatal melanocyte cul tures (app roximately 40,000 cells/well) had been 
established and mai ntained in mediu m with T IC fo r 3 months and were exposed 
to the experimental medium in duplicate wells fo r 5 days. In corpo rat ion of 
IJH] thymid ine was assayed during the fma l 3 h of incuba tion, and data arc given 
as average cpm ± SE. IC: medium supplemented w ith 0. 1 111 M IBM X and 2.5 nM 
CT. 
RD (Table IV) which continued to proliferate at a constant, high 
rate for more than 3 months and 7 passages in culture. Both th eir 
appearance and growth rate resembled th ose of neonatal mela-
nocytes probably because the nevus cam e from a 9-year-old child 
rather than an adult. T he addition of WI-38 cell extract to TIC 
or IC (medium supplemented with 0. 1 mM IBMX and 2.5 nM 
CT) did not reinitiate cell division in quiescent nevus cultures 
(data not shown) . Placental extract supported the proliferation o f 
melanocytes fro m dys plas tic and congenital nevi, but only in the 
presence of IC (data not show n) . . 
The growth of melanocytes from metas tatic melano mas, tested 
within the fi rst week in culture and weeks later, was inhibited by 
TPA, with or without IBMX plus CT (Table V), and by IBMX 
plus CT without TPA (data not shown) . The morphology of 
these metas tatic melanoma cells was altered within 5 h of addition 
of TPA alone, or in combination w ith IBMX and CT (Fig 4), 
and growth was arrested within 24 h. The melanoma PC is amel-
anotic and contains low tyrosinase activity (1.4 /LU / m g protein). 
TP A caused a 3-fo ld increase in tyrosinase activity. The concen-
tration-dependent arrest of metas tatic melanoma cells in response 
to TPA is presented in Fig 5. Human fibroblasts, derived from 
newborn foreskins, were used as control cells to test whether 
TPA caused grow th arres t in another cell type that was not de-
pendent on TPA for growth in culture. These data show that 
both types of cells were sensitive to T P A and that melanoma cells 
were more sensiti ve than fib roblas ts. 
WI-38 cell extract that stimulated the grow th of neonatal mel-
anocytes (HFSC 400) inhibi ted the growth of fas t-growing (PC) 
but not of slow-growing (LG) metastatic melano ma cells (Ta-
ble VI). 
DISCUSSIO N 
M ost studies on the biologic properti es of melano mas in human 
beings have been res tricted to his tologic and immunologic anal-
yses of lesions in situ and the use of cells from metas tases in 
cultu re. T he classifi ca tion of prim ary melanomas according to 
C lark level and Breslow depth [11 ,12] has been useful in providing 
information w ith rega rd to prognosis. For example, nodul ar mel-
anomas and primary lesions having a depth greater than 0.76 mm 
metas tas ize more readily than superfi cial spreading melanomas 
[13,14]. Information has also been obtained by the use of mono-
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Figure 2. Representati ve phase contras t m icrographs of melanocytes cul-
tu red fro m no rmal skin, nevi, and a prim ary melano m a. All cell s were 
grown in med ium supplem ented w ith T PA , IBMX, and CT (TIC). A, 
Melanocytes fro m newbo rn fo reskin. B, Melanoctyes fro m adul t skin. 
C, D ysp lastic nevus MM . D, D ysplas ti c nevus PS. E and F, Dysplastic-
congeni ta l nevus RP taken during the 6th and 8th m onths in culture, 
respectively. C, Congenital nevus CQ. H , Primary melano m a M D. All 
exa mples were photographed at the time the ce ll s were assayed for 
[3H]th y' midine incorpo ration (sec Tables II and III). x 132. 
clonal antibodies [1 5- 21]. It was found that the major class II 
histocompatibility anti gen H LA-DR was expressed in deep pri-
mary lesions, particularl y by cells of the invad ing front, and in 
metas tases. O ther antigens are also associated with either primary 
or metas tati c melanomas. 
The dependence for grow th of normal human melanocytes on 
the synergisti c action of specific mitogens and the independencr 
)~ 
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Table IV. Growth of Melanocytes from Normal Adult Skin, Nevi, and Primary Melanoma 
Growth Rate 
Experimental Culture Conditions 
Culture Grown in TIC 
TIC (100%) No additions 
Donor Passage Number Weeks (cpm/3 h :t SE) (%) 
Adult, noninvolved skin 
KB 1 st 4 120 :t 20 NDA 
DR 1st 5 420 :t 35 ~DA 
Dysplastic nevi 
LD 
Nevus 1 1st 1 17,000 :t 1,200 29 
Nevus 2 1st 3 7,000 :t 413 9 
Nevus 3 1 st 3 6,700 :t 420 15 
JZ 1 st 2 420 :t 195 NDA 
MM 1 st 2 22,000 :t 703 17 
PS 1st 4 NDA NDA 
Congenital compound nevus 
RD 3rd 4 14,000:t 620 NDA 
6th 10 10,000 :t 520 2 
TS 3rd 12 1,200 :t 50 8 
4th 10 NDA NDA 
CQ 2nd 3 3,000 :t 250 27 
SA 3rd 12 450 :t 30 16 
MH 4th 6 19,000:t14 2 
5th 8 247 :t 4 NDA 
Dysplastic compound nevus with 
primary melanoma 
RP 
Dysplastic nevus part 2nd 6 800 :t 75 15 
3rd 24 7,000 :t 300 4 
6th 40 100 :t 8 NDA 
MD 
Dysplastic nevus part 1st 2 5,000 :t 450 24 
Melanoma part 1st 2 6,150:t 110 20 
The adult donor KB was a 3D-year-old male (biopsy from right Rank), and DR was a 49-year-old male (biopsy from left Rank) . Dysplastic nevus RP had a melanoma, 
but o nly the nonmalignant part was given for tissue culture. For more details sec footnote to Table 11 . NDA = no detectable activity . 
from these mitogens of fully neoplas tic melanocytes may also 
help us characterize the phenotypic changes that occur during 
transformation to malignancy. One class of mitogens are sub-
stances that increase intracellular levels of cyclic adenosine mono-
phosphate (cAMP), such as IBMX and CT. Thus, growth in-
dependence may involve a transition to constitutively high levels 
of cAMP or to an acquisition of a cAMP-independent protein 
kinase activity. The other mitogen needed for normal melanocyte 
proliferation seemed to be ubiquitous in fast-dividing cells that 
do not require TP A and in expanding tissues, such as placenta. 
Melanocytes from congenital and dysplastic nevi needed TIC 
(or placenta extract plus Iq for optimal growth, although the 
loss of DNA synthetic activity upon removal of TIC was not as 
drastic as in melanocytes from newborn foreskins or adult skin. 
After removal of TIC from neonatal melanocytes for 5 days, the 
DNA synthetic activity dropped as low as 3% or less in most of 
the cultures, whereas some cultures from dysplastic nevi main-
tained as much as 25-30% of the DNA synthetic activity ex-
Table V. Growth of Melanocytes from Metastatic Melanomas 
Donor 
TA" 
SR 
PC 
EJ 
JH 
MS 
LG 
Culture 
Passage Number 
3rd 
1st 
1st 
8th 
1st 
10th 
1st 
3rd 
Weeks 
5 
1 
2 
29 
6 
24 
1 
20 
Growth Rate 
Experimental Culture Conditions 
TIC TPA No Additions 
(%) (%) (cpm/3 h + SE (100%) ) 
1.3 6.3 8,000 :t 400 
4.3 8.2 14,000 :t 220 
20.0 16.0 50,000 :t 900 
10.0 8.1 12,000 :t 600 
8.0 ND 9,200 :t 36 
58.0 23.3 12,000 ± 422 
53.3 81.0 60,000 :t 1000 
ND 25.6 7,400 ± 190 
The cells (seeded at approximately 80,OOD/well) were maintained in the experimental medium for 2 days. Most were from cultures grown without TIC (no additions) 
excep t for PC cells during the 1 st passage. The latter were taken from a culture incubated in medium supplemented with TIC. Each entry is an average value from 2 wells. 
Standard error (SE) did not exceed 10%. NO = not determined . 
'A melanoma (C81-46A) obtained from Dr. F. Myskens, Tucson, AZ. 
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WEEKS IN CULTURE 
Figure 3. Growth rate in culture of melanocytes from 2 dysplastic nevi. 
Data are given as percent of [3H]thymidine incorporation in comparison 
with that of neonatal melanocytes of the same age and passage in cultu re. 
T he level of [3H]th ymidine incorporation of the neonatal melanocyte 
cultures was 30,000 cpm/3 h. C losed circles, dysplastic nevus MM; opell 
circles, dysplastic nevus LD. See Tables I and IV for details regarding 
origin and culture requirements of these 2 nevi . 
pressed in para llel cultures grown with T IC. [3H]Thymidinc in-
corpo ratio n in thc prcsence oflB M X and CT on ly, i.c., withou t 
TPA, was simil ar to that in m edium w ith no additions (data not 
shown) . The fac t that melanocytes cultured from nevi looked and 
behaved differcntly from mel anocytes from no ninvo lved skin 
suggests that we succceded in g rowin g nevus pigment cells. 
M elanocytes from primary m elanom as survived better in the 
p resence than in the absence of T IC. However, succcss in o b-
tainin g large numbers of such cells, o r even m elanocytes from 
some cutaneous m etastases, is s till extrcmely small. This d ifficu lty 
mig ht be overcome by substituting TPA w ith placcnta l extract. 
Our preli minary experience shows that placen tal extract is stim-
ulatory to both norm al and m aligna nt m elanocytes. It should also 
be noted that melanocytcs that grow from primary m elanomas 
that arose in a dysplastic nevus in the presence of T IC might be 
the nevus melanocytes rather than transformed pigment cells . 
Further studies will show whether the transformed melanocytes 
that require mitogens for g rowth are different fro m n t;vus cells 
in their abi li ty to proli ferate contin uo usly in culture (immortal-
ized) or in specific m arkers such as an abnormal karyotype or the 
expression of a transform ation-specific antigen . 
Table VI. Effect of W I-38 Ccll Extract o n the G rowth of 
N o rm al and M ali g nant M elanocytes 
Culture Conditions 
No addition 
TPA 
WI38, 50 ILg/ml 
WI3S, 5 ILg/m l 
Melanocyte Growth Rate 
Normal 
HFSC 400 
250 ± 9 
2,SOO ± 100 
15,500 ± 450 
20,000 ± 210 
Malignant 
PC 
20.000 ± 1.105 
2,000 ± 200 
9,530 ± 390 
13,000 ± 640 
LG 
7,350 ± 190 
l ,S20 ± SO 
7,620 ± 650 
5,590 ± 360 
Human melanocytes from a foresk in (HFSC) were grown in cu lture with TIC 
ror 2 months and were passed 5 times. The malignant mcl;1Ilom:t cell s were grown 
in medium without additions. The PC melalloma was in culture for 10 months and 
passed 18 times. The LG melanoma was in culture [or 5 months and passed 3 times. 
The mclanocyrcs were in rhe ex perimenta l medium in dupli cate 4-(1112 wells for 4 
days. Medium was changed I day prior to growth assay. Each cntry is an average 
va luc (cpm) of [lHlthymidine incorporation during the final 2-h period of incuba-
tion. 
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Figure 4. Phase contrast micrographs of metastatic melanoma cells growt\ 
in di fferent media . Cells from patient PC were grown in culture for < 
months in melanoma medium (A) , fo llowed by 1 day in experimental 
medium: 8, T PA ; C, T IC [ce lls receiving IBMX and CT without TPA 
looked like those in (A) ]. Note the rounding of ce lls in response to TPA 
in (8) and the spind led appea rance in response to T IC in (C) . X 132. 
Unexpected responses to TPA wcre o bserved w ith meJanocytc~ 
from those metastatic m elano m as w hose ccll s did no t rcqu.ir~ 
grow,th factors to proli ferate in culture. T PA, and to a lesser exten\ 
WI-38 cell extrac t , inhibited the g rowth of these cells. T here wa\ 
a 99.9% reduction in (3H]th y midine incorporation into melanom~ 
cells at a TPA concentratio n (85 11 M) th at was o ptimal for th 
growth of neonatal m elanocytes and that ca used o nl y 50-60o/~ 
inhibition in fibrobl asts. Other investigators also repo rted growt~ 
retardation and m orpho logic changes in m etastatic melanoma cell\ 
in response to TPA [22] . TPA cau sed an in crease in t yros in as~ 
activity of the am elanotic m e lanoma cells . T herefo re, the growt~ 
inhibition can be regarded as a conseq uence of induced differ\ 
entiation. H owever, TPA also in creased tyros inase activity il\ 
normal hum an melanocytes with a concomitant increase in cell 
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Figure 5. Growth n:sponsc of metas tati c mel ano ma cel ls to TPA. Meta-
static mci anoma PC (Tab lc:s I and V and Fi g 4) and normal fibroblasts 
fro m new bo rn foreskin . grown in culture in mcianoma medium for 2 
months , were seeded in 4-cm2 cluster we lls and incubated for 2 days in 
mediuIll supplemented with different concentrations o f TPA (without 
IBM X and CT). Cells were radiolabded with I"HJth ymidinc for 1 h. 
[JH]Thymidine incorpora tion is expressed as percentage of contro l va lues 
(no TPA) . Contro l va lucs for metastatic melanoma PC and fibroblasts 
were 27,000 and 165,000 cpm, res pectivel y. Approximatcly 100,000 cells 
were in cach well. and duplica te we lls werc used for each treatment . 
Standard crro r betwcen duplicate we lls is indica tcd by the "mical bars . 
growth [23J. TPA is kn own to ca use e ith er inhibition or stim-
ulation of g rowth , d ependin g on th e cellul a r syste m used, prob-
ably due to phos pho rylation of d ifferent proteins and activa tion 
of different pro te in kinases 1'241 · Th us, th e effects of TPA are 
analogous to those of th e type f3 tran sformin g g rowth factor 
(TG F-f3) , a lso known to be a po tent st imulato r of g rowth for 
so m e cell t y pes, but an inhibitor of grow th for other cells [7J . 
The fact tha t both WI-38 cell extra ct and TPA promote the 
growth of norm al mcl anocy tes but inhibit the g rowth of inde-
pendently pro li fe ra tin g m etasta ti c m elanom.a cells indica tes th at 
the phorbo l es te r acts like so m e natural g rowth factors a t a site 
that is pivota l in reg ul a tin g the g rowth of m elanocytes. Havin g 
mel an oct yes from d ifferent kinds of les io ns in culture will enable 
u s to inves ti ga te furth er their requirm ents for g rowth, their pro-
liferative li fe s pan, and the expression o f grow th-related .gen e 
products at various stages of prog ress io n into malig nancy. 
T he allthors thallk Drs. B. RichIeI' ,,"d S. Ariy"" Jo r providillg the biopsy 
speci/ll ells, Dr. C. MOI'I//Ila//Ilji)r editillg, C. Koch crJor Iypillg the )Il"'"lscript, 
alld Alldre), Traillcrjill' ll lllilltaillillS the cell w ltlll l·S. 
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